NCT06630299 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06630286 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06613685 Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated Status TERMINATED Phase PHASE2/PHASE3
NCT06612203 Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] Status COMPLETED Phase N/A
NCT06585189 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4] Status COMPLETED Phase N/A
NCT06585150 Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection Status TERMINATED Phase PHASE2
NCT06562907 Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) Status RECRUITING Phase PHASE1
NCT06544733 Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 Status RECRUITING Phase PHASE2/PHASE3
NCT06532565 Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06528483 Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06525389 Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST) Status NOT_YET_RECRUITING Phase PHASE3
NCT06513312 Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06477419 A Study of Sacituzumab Govitecan in People With Mesothelioma Status RECRUITING Phase PHASE2
NCT06465862 Development of a Silica Microparticle Taggant System to Measure ART Adherence Status WITHDRAWN Phase NA
NCT06401824 Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases Status RECRUITING Phase PHASE2